Related Experiment Video
Updated: Jul 13, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer
Sandra Karlsson1, Erik Holmberg, Anders Askerlund
1Department of Biomedicine, School of Life Sciences, University of Skövde, Box 408, SE-541 28 Skövde, Sweden. sandra.karlsson@his.se
Cancer Genetics and Cytogenetics
|August 19, 2007
Summary
This study investigated endometrial cancer in rats, finding key differences in transforming growth factor-beta (TGF-beta) pathway genes between cancerous and normal endometrial cells. These TGF-beta pathway gene expression changes may influence endometrial adenocarcinoma development.
Area of Science:
- Gynecologic Oncology
- Cancer Genetics
- Molecular Biology
Background:
- Endometrial cancer is a prevalent gynecologic malignancy.
- BDII inbred rats are highly susceptible to spontaneous endometrial adenocarcinoma (EAC), making them a valuable model.
- Previous research indicated repressed transforming growth factor-beta (TGF-beta) signaling in EAC carcinogenesis.
Purpose of the Study:
- To analyze gene expression profiles in endometrial tumor and nonmalignant cell lines.
- To identify genes within the transforming growth factor-beta (TGF-beta) pathway that are differentially expressed.
- To investigate the role of TGF-beta pathway aberrations in endometrial adenocarcinoma development.
Main Methods:
- Gene expression profiling using cDNA microarrays on endometrial tumor and nonmalignant cell lines.
- Clustering and statistical inference analyses to identify differentially expressed genes.
- Validation of gene expression using semiquantitative reverse-transcription polymerase chain reaction.
Main Results:
- Several genes within the transforming growth factor-beta (TGF-beta) pathway were found to be differentially expressed between endometrial tumor and nonmalignant cell lines.
- Aberrations in the expression of TGF-beta downstream target genes were identified.
- These findings were confirmed through independent gene expression analysis.
Conclusions:
- The study identified significant alterations in the expression of TGF-beta pathway genes in endometrial adenocarcinoma.
- These molecular changes in TGF-beta signaling may play a crucial role in the carcinogenesis of endometrial adenocarcinoma.
- The identified gene expression irregularities provide insights into the mechanisms underlying EAC development.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...